1997

• GENESIS Pharma is established with the objective to market and distribute new, advanced pharmaceutical products resulting primarily from biotech research.
• Exclusive Agreement signed with Biogen for Avonex^® in Greece.
• Exclusive Agreement signed with Vifor for Venofer^® in Greece.

1998

• Exclusive Agreement signed with Lafon (now merged with Cephalon) for Modiodal^® in Greece and Cyprus.

1999

• GENESIS Pharma (Cyprus) Ltd. is established.
• Exclusive Agreement signed with PathoGenesis (now merged with Chiron Corp.) for Tobi^® in Greece and Cyprus.
• Contract extended with Biogen for Avonex^® in the Balkans and Cyprus.

2000

• Exclusive Agreement signed with Amgen for Aranesp^® in Greece and Cyprus.
• Chiron awards GENESIS Pharma the "Certificate of Excellence" for the Best Performing European Tobi^® team.

2001

• GENESIS Pharma establishes a representative office in Romania.
• "Distributor of the Year" Award, by Biogen for Avonex^® .

2002

• Exclusive Agreements signed with Amgen for the distribution of Granulokine^® and Neulasta^® in Greece and Kineret^® in Greece and Cyprus.
• Exclusive Contract signed with Shire for the distribution of Xagrid^® in Greece and Cyprus.
• "Distributor of the Year" Award, by Biogen for Avonex^® .

2003

• "Corporate Social Responsibility" Award (Annual National Advertising & PR Congress) for an awareness-raising programme for Multiple Sclerosis patients in Greece.
• "Excellence and Outstanding Sales Performance" Award, by Amgen.
• Voted 8th Company in the 2003 Best Workplaces^® Competition in Greece.
• "Distributor of the Year" Award, by Biogen Idec for Avonex^® .

2004

• GENESIS Pharma establishes a representative office in Bulgaria.
• Awarded "Certificate of Recognition" at The Economist Corporate Social Responsibility Forum, for outstanding achievement in corporate social responsibility and sustained business performance.
• Voted 7th in the 2004 Best Workplaces^® Competition in Greece.
• File submitted for listing in the Athens Stock Exchange.

2005

• Voted 5th in the 2005 Best Workplaces^® Competition in Greece
• Voted among the top 100 companies to work for in the 2005 Best Workplaces^® Competition in Europe.

2006

• Exclusive Agreement signed with Alfacell Corporation for the commercialization of ONCONASE^® in Greece, Cyprus, Bulgaria, Romania, Slovenia, Croatia and F.Y.R.O.M.
• Exclusive Agreement signed with IDM Pharma for the distribution of Junovan^TM in Greece, Cyprus, Bulgaria, Romania, Slovenia, Croatia and F.Y.R.O.M.
• Exclusive Agreement signed with Celgene Corporation.
• Voted 3th in the 2006 Best Workplaces^® Competition in Greece
• Voted, for second consecutive year, among the top 100 companies to work for, in the 2006 Best Workplaces^® Competition in Europe.
• Mr C.Evripides, GENESIS Pharma CEO, was voted as the "Rapidly Developing Entrepreneur of the Year 2006" in the international competition «Entrepreneur Of The Year".
• GENESIS Pharma has been listed No. 316 among the fastest growing European companies included in the 2006 Europe's 500 Listing, the annual ranking of high growth, job-creating companies published by Europe's 500 - Entrepreneurs for Growth.